Fundamentals Hub
VTVT vTv Therapeutics Inc.
VTVT financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 13 annual and 0 of 47 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$22.36M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
336-841-0300
EIN
473916571
Headquarters
HIGH POINT, NC, 27265
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
$36.84M
Net Income
$-4.76M
Total Assets
$87.59M
Total Equity
$78.63M
Total Debt
-
Free Cash Flow
-
Ratios
Operating Margin
-25.1%
Net Margin
-12.9%
Return on Equity
-6%
Return on Assets
-5.4%
Current Ratio
12.48x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $0 | $1.02M | $0 |
| OPERATING EXPENSES | |||
| R&D Expense | $17.86M | $11.55M | $13.60M |
| SG&A Expense | $14.95M | $13.65M | $11.91M |
| Operating Income | $-32.81M | $-24.18M | $-25.50M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Expense | - | - | $13.00K |
| Interest Income | $1.87M | $1.57M | $472.00K |
| Other Income/Expense | - | - | $-1.50M |
| Pretax Income | $-31.08M | $-22.61M | $-25.97M |
| Income Tax | $0 | $100.00K | $0 |
| Net Income | $-26.97M | $-18.46M | $-20.25M |
| PER SHARE & SUPPLEMENTAL | |||
| EBITDA | $-32.79M | $-24.09M | $-25.41M |
| Depreciation & Amortization | $16.00K | $89.00K | $90.00K |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $88.93M | $36.75M | $9.45M |
| Accounts Receivable | - | $62.00K | $102.00K |
| Other Current Assets | $218.00K | $1.22M | $1.04M |
| Current Assets | $89.89M | $38.11M | $10.66M |
| PP&E (Net) | - | $28.00K | $117.00K |
| Other Noncurrent Assets | $6.00K | $153.00K | - |
| Noncurrent Assets | $6.00K | $153.00K | $361.00K |
| Total Assets | $89.90M | $38.27M | $11.02M |
| LIABILITIES | |||
| Accounts Payable | $1.13M | $939.00K | $4.08M |
| Other Current Liabilities | $299.00K | $316.00K | $300.00K |
| Current Liabilities | $6.64M | $5.20M | $10.62M |
| Noncurrent Liabilities | $18.82M | $18.77M | $18.95M |
| Total Liabilities | $25.46M | $23.97M | $29.57M |
| EQUITY | |||
| Additional Paid-in Capital | $391.09M | $311.89M | $256.34M |
| Retained Earnings | $-326.69M | $-299.72M | $-281.04M |
| Total Equity | $64.44M | $14.30M | $-24.68M |
| Temporary Equity | - | $0 | $6.13M |
| Total Liabilities & Equity | $89.90M | $38.27M | $11.02M |
| SUPPLEMENTAL | |||
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-25.26M | $-25.31M | $-19.08M |
| Capital Expenditures | - | $0 | $0 |
| Cash from Investing | $0 | $0 | $4.40M |
| Cash from Financing | $77.44M | $52.61M | $12.00M |
| Free Cash Flow | - | $-25.31M | $-19.08M |
| Beginning Cash (CFS) | $36.75M | $9.45M | $12.13M |
| Net Change in Cash | $52.19M | $27.30M | $-2.68M |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $88.93M | $36.75M | $9.45M |
| Cash per BS | $88.93M | $36.75M | $9.45M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $88.93M | $36.75M | $9.45M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is vTv Therapeutics Inc.'s annual revenue?
vTv Therapeutics Inc. reported $36.84M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is vTv Therapeutics Inc. profitable?
No. vTv Therapeutics Inc. reported $-4.76M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.